SCHEMBL5500240

SCHEMBL5500240

NC(=O)c1cc2cc(S(N)(=O)=O)ccc2n1S(=O)(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
HDAC3 O15379 5/20 0.48
HDAC4 P56524 5/20 0.48
HDAC1 Q13547 5/20 0.48
HDAC7 Q8WUI4 5/20 0.48
HDAC2 Q92769 5/20 0.48
HDAC10 Q969S8 5/20 0.48
HDAC11 Q96DB2 5/20 0.48
HDAC8 Q9BY41 5/20 0.48
HDAC6 Q9UBN7 5/20 0.48
HDAC9 Q9UKV0 5/20 0.48
HDAC5 Q9UQL6 5/20 0.48
LMNA P02545 2/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
CCR2 P41597 1/20 0.46
PPARG P37231 5/20 0.44
PPARA Q07869 5/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3836440 0.85 ALDH1A1 (0.62) CA12CA2CA9HDAC3HDAC4
SCHEMBL3837213 0.84 PPARG (0.61) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2954808 0.82 HDAC3 (0.47) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL12804418 0.78 HDAC3 (0.53) CA12CA2CA9HDAC3HDAC4
SCHEMBL4053686 0.77 CA2 (0.52) CA12CA2CA9HDAC3HDAC4
SCHEMBL4035724 0.75 ALDH1A1 (0.52) CA12CA2CA9HDAC3HDAC4
SCHEMBL31579035 0.74 HTR6 (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2928475 0.73 PTGS2 (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4551501 0.73 SRC (0.46) CA12CA2CA9LMNAALDH1A1
SCHEMBL741459 0.73 ACLY (0.64) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776106-A1 HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS Vertex Pharmaceuticals Incorporated (US) 2007-04-25 EP disclosed
WO-2006010008-A1 HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-01-26 WO disclosed